Physician profile
Christopher Snell
NPI 1134563950
$2,828.67
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,454 · 2020: $21.61 · 2021: $332 · 2022: $20.98.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,105.57 | 2019 | |
| Bard Peripheral Vascular, INC. | $331.59 | 2021 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Medtronic USA, INC. | $168.49 | 2019 | |
| Venclose INC. | $21.61 | 2020 | |
| Galderma Laboratories, L.P. | $20.98 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Snell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.